v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenue:    
License and collaboration revenue   $ 10,000
Total revenue   10,000
Operating expenses:    
Research and development $ 60,439 34,915
General and administrative 16,911 12,415
Total operating expenses 77,350 47,330
Loss from operations (77,350) (37,330)
Other income (expense), net:    
Interest expense on royalty obligation (6,263)  
Interest expense on senior secured term loan (368)  
Interest income 3,018 3,394
Other (expense) income, net (24) 158
Total other income (expense), net (3,637) 3,552
Loss before income taxes (80,987) (33,778)
Income tax provision (benefit)   (205)
Net loss $ (80,987) $ (33,573)
Net loss per share - basic (in dollars per share) $ (1.46) $ (0.8)
Net loss per share - diluted (in dollars per share) $ (1.46) $ (0.8)
Weighted-average common stock outstanding - basic (in shares) 55,624,631 41,800,802
Weighted-average common stock outstanding - diluted (in shares) 55,624,631 41,800,802
Comprehensive loss:    
Net loss $ (80,987) $ (33,573)
Other comprehensive income (loss):    
Unrealized (loss) gain on investments (341) 12
Foreign currency translation adjustment 28 (65)
Comprehensive loss $ (81,300) $ (33,626)